870 filings
NT 10-K
ELOX
Eloxx Pharmaceuticals, Inc.
1 Apr 24
Notice of late annual filing
4:02pm
8-K
ELOX
Eloxx Pharmaceuticals, Inc.
29 Mar 24
Departure of Directors or Certain Officers
4:11pm
25-NSE
The Nasdaq Stock Market LLC
21 Mar 24
Exchange delisting
2:20pm
8-K
ELOX
Eloxx Pharmaceuticals, Inc.
14 Mar 24
Entry into a Material Definitive Agreement
4:30pm
4
ELOX
Eloxx Pharmaceuticals, Inc.
26 Jan 24
Eloxx Pharmaceuticals / Alan Edmund Walts ownership change
4:33pm
4
ELOX
Eloxx Pharmaceuticals, Inc.
26 Jan 24
Eloxx Pharmaceuticals / Steven D Rubin ownership change
4:33pm
4
ELOX
Eloxx Pharmaceuticals, Inc.
26 Jan 24
Eloxx Pharmaceuticals / Lindsay Androski ownership change
4:32pm
4
Sumit Aggarwal
26 Jan 24
Eloxx Pharmaceuticals / Sumit Aggarwal ownership change
4:32pm
S-3
ELOX
Eloxx Pharmaceuticals, Inc.
Shelf registration
24 Jan 24
9:44pm
S-8
ELOX
Eloxx Pharmaceuticals, Inc.
24 Jan 24
Registration of securities for employees
5:11pm
8-K
ELOX
Eloxx Pharmaceuticals, Inc.
9 Jan 24
Entry into a Material Definitive Agreement
5:10pm
8-K
ELOX
Eloxx Pharmaceuticals, Inc.
28 Dec 23
Departure of Directors or Certain Officers
4:11pm
8-K
ELOX
Eloxx Pharmaceuticals, Inc.
15 Dec 23
Entry into a Material Definitive Agreement
4:10pm
8-K
ELOX
Eloxx Pharmaceuticals, Inc.
13 Nov 23
Eloxx Pharmaceuticals Reports Third Quarter 2023 Financial and Operating Results and Provides Business Update
4:58pm
10-Q
2023 Q3
ELOX
Eloxx Pharmaceuticals, Inc.
Quarterly report
13 Nov 23
4:10pm
8-K
ELOX
Eloxx Pharmaceuticals, Inc.
16 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:26pm
8-K
ELOX
Eloxx Pharmaceuticals, Inc.
20 Sep 23
Entry into a Material Definitive Agreement
4:05pm
424B5
ELOX
Eloxx Pharmaceuticals, Inc.
20 Sep 23
Prospectus supplement for primary offering
1:26pm
8-K
ELOX
Eloxx Pharmaceuticals, Inc.
18 Sep 23
Other Events
8:05am
8-K
ELOX
Eloxx Pharmaceuticals, Inc.
15 Sep 23
Departure of Directors or Certain Officers
5:15pm